News
EU regulators greenlight twice-yearly HIV injection, hailed
Africanews on MSN26d
Looming funding shortfall could reverse global progress against AIDS, warns UNAIDS chiefWithout bold action, Byanyima warned, the world could witness 6.6 million new HIV infections by the end of the decade.
The UNAIDS annual report warns that Trump-era HIV funding cuts could lead to 6 million more infections and 4 million deaths by 2029 — as low-income countries struggle to fill the gap.
Even before the US funding cuts, progress against curbing HIV was uneven. UNAIDS said that half of all new infections are in sub-Saharan Africa and that more than 50 per cent of all people who ...
CHENNAI: Gilead Sciences has achieved another milestone in its efforts to bring in a preventive drug to curb the still ...
UNAIDS warns of a global HIV crisis as U.S. funding cuts disrupt health ... U.S. withdrawal of $4 billion in AIDS funding risks over 4 million deaths and 6 million new HIV infections by 2029.
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention as a tool in their efforts to fight HIV infections – especially for groups most ...
The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.. The drug will be ...
BROOKS: Well, you know, HIV research has been in place since the discovery of the virus as the cause of advanced HIV disease, which we used to call AIDS. And it's, you know, made incredible ...
“The bold financial commitment made by Côte d’Ivoire is a powerful example of what political will and national leadership can achieve in the HIV response,” said Ms Byanyima. “Domestic financing is the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results